(Q85612456)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212153%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

title

The influence of hypoxia on CML trafficking through modulation of CXCR4 and E-cadherin expression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212153%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

A K Azab

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212153%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

E Weisberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212153%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

I Sahin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212153%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

F Liu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212153%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

R Awwad

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212153%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

F Azab

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212153%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Q Liu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212153%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

J D Griffin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212153%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

I M Ghobrial

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212153%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

publication date

5 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212153%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212153%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212153%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212153%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

961-964

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212153%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2012.353

19 February 2020

exact match

0 references

cites work

Localization of BCR-ABL to F-actin regulates cell adhesion but does not attenuate CML development

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.353

7 January 2021

Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.353

7 January 2021

Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.353

7 January 2021

Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.353

7 January 2021

Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.353

7 January 2021

CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.353

7 January 2021

Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+ cell to Imatinib and Nilotinib

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.353

7 January 2021

Hypoxia suppresses BCR/Abl and selects imatinib-insensitive progenitors within clonal CML populations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.353

7 January 2021

HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.353

7 January 2021

Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.353

7 January 2021

Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.353

7 January 2021

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.353

7 January 2021

Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.353

7 January 2021